Drug Therapy

Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 4: A Status Report on Physical Modalities and Devices

Author and Disclosure Information

The fourth article in this 5-part series reviews physical modalities and devices used to treat cutaneous rosacea based on consensus recommendations from the American Acne & Rosacea Society (AARS) on the management of the common presentations of cutaneous rosacea. The major therapeutic uses of physical modalities and devices, especially laser and light-based systems, are for treatment of telangiectases and persistent facial erythema (background erythema). Phymas, especially rhinophyma, also are treated with physical modalities such as ablative lasers or surgical devices (eg, electrosurgical loop). Appropriately selected and properly used lasers and intense pulsed light (IPL) devices can successfully address specific clinical manifestations of rosacea that exhibit limited or no response to available medical therapies, such as telangiectases and background centrofacial erythema. Rosacea-associated symptoms also may improve. In most cases, treatment will need to be repeated intermittently to sustain improvement.


 

Recommended Reading

High-dose isotretinoin restrains acne relapse
MDedge Dermatology
Product News: 09 2013
MDedge Dermatology
A primer on pediatric acne
MDedge Dermatology
New GI, topical approaches target rosacea
MDedge Dermatology
Azelaic acid 15% gel tames women’s acne
MDedge Dermatology
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care
MDedge Dermatology
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 2: A Status Report on Topical Agents
MDedge Dermatology
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea: A Randomized, Double-blind, Vehicle-Controlled Study
MDedge Dermatology
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 3: A Status Report on Systemic Therapies
MDedge Dermatology
Botulinum toxin tantalizes as a rosacea tamer
MDedge Dermatology

Related Articles